Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
- PMID: 28702674
- PMCID: PMC5961066
- DOI: 10.1167/iovs.17-22339
Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
Erratum in
-
Erratum.Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3960. doi: 10.1167/iovs.17-22339a. Invest Ophthalmol Vis Sci. 2017. PMID: 28793146 Free PMC article. No abstract available.
Similar articles
-
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.Invest Ophthalmol Vis Sci. 2008 Feb;49(2):479-89. doi: 10.1167/iovs.07-1132. Invest Ophthalmol Vis Sci. 2008. PMID: 18234989 No abstract available.
-
Core outcomes for geographic atrophy trials.Br J Ophthalmol. 2020 Sep;104(9):1196-1202. doi: 10.1136/bjophthalmol-2019-314949. Epub 2019 Dec 17. Br J Ophthalmol. 2020. PMID: 31848211
-
Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration.Ophthalmology. 2016 May;123(5):1060-79. doi: 10.1016/j.ophtha.2016.01.034. Epub 2016 Mar 5. Ophthalmology. 2016. PMID: 26952592 Review.
-
Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.Semin Ophthalmol. 2011 May;26(3):167-80. doi: 10.3109/08820538.2011.577132. Semin Ophthalmol. 2011. PMID: 21609230 Review.
-
Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration.Retina. 2011 Jul-Aug;31(7):1323-31. doi: 10.1097/IAE.0b013e31820a6850. Retina. 2011. PMID: 21540764
Cited by
-
Effectiveness of Mp-3 Microperimetric Biofeedback Fixation Training For Low Vision Rehabilitation in Patients Treated With Corticosteroid Ivt in Retinal Vein Occlusions.Clin Optom (Auckl). 2024 May 22;16:131-142. doi: 10.2147/OPTO.S460999. eCollection 2024. Clin Optom (Auckl). 2024. PMID: 38798785 Free PMC article.
-
Relationship Between Acuity and Contrast Sensitivity: Differences Due to Eye Disease.Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):40. doi: 10.1167/iovs.61.6.40. Invest Ophthalmol Vis Sci. 2020. PMID: 38755787 Free PMC article.
-
Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months.JAMA Ophthalmol. 2024 Jun 1;142(6):548-558. doi: 10.1001/jamaophthalmol.2024.1269. JAMA Ophthalmol. 2024. PMID: 38722644 Free PMC article. Clinical Trial.
-
[Complement inhibition treatment for geographic atrophy (GA): functional and morphological efficacy and relevant biomarkers in clinical practice].Ophthalmologie. 2024 Jun;121(6):476-481. doi: 10.1007/s00347-024-02039-z. Epub 2024 Apr 30. Ophthalmologie. 2024. PMID: 38691156 Review. German.
-
Retinal Imaging Findings in Inherited Retinal Diseases.J Clin Med. 2024 Apr 3;13(7):2079. doi: 10.3390/jcm13072079. J Clin Med. 2024. PMID: 38610844 Free PMC article. Review.
References
-
- Schmitz-Valckenberg S, Brinkmann CK, Alten F,et al. . Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration. . 2011; 52: 7640– 7646. - PubMed
-
- Vitale S, Clemons TE, Agron E,et al. ; for the Age-Related Eye Disease Study 2 Research Group. . Evaluating the validity of the age-related eye disease study grading scale for age-related macular degeneration: AREDS2 report 10. . 2016; 134: 1041– 1047. - PubMed
-
- Abdelfattah NS, Zhang H, Boyer DS,et al. . Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye. . 2016; 57: 1839– 1846. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical